440 related articles for article (PubMed ID: 27050566)
1. Efficacy of a Guideline-Recommended Risk-Reduction Program to Improve Cardiovascular and Limb Outcomes in Patients With Peripheral Arterial Disease.
Hussain MA; Al-Omran M; Mamdani M; Eisenberg N; Premji A; Saldanha L; Wang X; Verma S; Lindsay TF
JAMA Surg; 2016 Aug; 151(8):742-50. PubMed ID: 27050566
[TBL] [Abstract][Full Text] [Related]
2. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease.
Armstrong EJ; Chen DC; Westin GG; Singh S; McCoach CE; Bang H; Yeo KK; Anderson D; Amsterdam EA; Laird JR
J Am Heart Assoc; 2014 Apr; 3(2):e000697. PubMed ID: 24721799
[TBL] [Abstract][Full Text] [Related]
3. Atherosclerotic disease and risk factor modification in Saudi Arabia: a call to action.
Al-Omran M
Vasc Health Risk Manag; 2012; 8():349-55. PubMed ID: 22701328
[TBL] [Abstract][Full Text] [Related]
4. Association of Statin Dose With Amputation and Survival in Patients With Peripheral Artery Disease.
Arya S; Khakharia A; Binney ZO; DeMartino RR; Brewster LP; Goodney PP; Wilson PWF
Circulation; 2018 Apr; 137(14):1435-1446. PubMed ID: 29330214
[TBL] [Abstract][Full Text] [Related]
5. Association of Ankle-Brachial Indices With Limb Revascularization or Amputation in Patients With Peripheral Artery Disease.
Moussa Pacha H; Mallipeddi VP; Afzal N; Moon S; Kaggal VC; Kalra M; Oderich GS; Wennberg PW; Rooke TW; Scott CG; Kullo IJ; McBane RD; Nishimura RA; Chaudhry R; Liu H; Arruda-Olson AM
JAMA Netw Open; 2018 Dec; 1(8):e185547. PubMed ID: 30646276
[TBL] [Abstract][Full Text] [Related]
6. Effects on Mortality and Cardiovascular Events of Adherence to Guideline-Recommended Therapy 4 Years after Lower Extremity Arterial Revascularization.
Thiney M; Della Schiava N; Ecochard R; Feugier P; Lermusiaux P; Millon A; Long A
Ann Vasc Surg; 2018 Oct; 52():138-146. PubMed ID: 29777848
[TBL] [Abstract][Full Text] [Related]
7. Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease: A Subanalysis of the COMPASS Randomized Clinical Trial.
Kaplovitch E; Eikelboom JW; Dyal L; Aboyans V; Abola MT; Verhamme P; Avezum A; Fox KAA; Berkowitz SD; Bangdiwala SI; Yusuf S; Anand SS
JAMA Cardiol; 2021 Jan; 6(1):21-29. PubMed ID: 32997098
[TBL] [Abstract][Full Text] [Related]
8. Adherence to lipid management guidelines is associated with lower mortality and major adverse limb events in patients undergoing revascularization for chronic limb-threatening ischemia.
O'Donnell TFX; Deery SE; Darling JD; Shean KE; Mittleman MA; Yee GN; Dernbach MR; Schermerhorn ML
J Vasc Surg; 2017 Aug; 66(2):572-578. PubMed ID: 28506476
[TBL] [Abstract][Full Text] [Related]
9. Association of Statin Therapy With Major Adverse Cardiovascular and Limb Outcomes in Patients With End-stage Kidney Disease and Peripheral Artery Disease Receiving Maintenance Dialysis.
Lo HY; Lin YS; Lin DS; Lee JK; Chen WJ
JAMA Netw Open; 2022 Sep; 5(9):e2229706. PubMed ID: 36048442
[TBL] [Abstract][Full Text] [Related]
10. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
Anand SS; Bosch J; Eikelboom JW; Connolly SJ; Diaz R; Widimsky P; Aboyans V; Alings M; Kakkar AK; Keltai K; Maggioni AP; Lewis BS; Störk S; Zhu J; Lopez-Jaramillo P; O'Donnell M; Commerford PJ; Vinereanu D; Pogosova N; Ryden L; Fox KAA; Bhatt DL; Misselwitz F; Varigos JD; Vanassche T; Avezum AA; Chen E; Branch K; Leong DP; Bangdiwala SI; Hart RG; Yusuf S;
Lancet; 2018 Jan; 391(10117):219-229. PubMed ID: 29132880
[TBL] [Abstract][Full Text] [Related]
11. Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial.
Hopley CW; Kavanagh S; Patel MR; Ostrom C; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Jones WS; Katona BG; Mahaffey KW; Norgren L; Rockhold FW; Hiatt WR
Vasc Med; 2019 Oct; 24(5):422-430. PubMed ID: 31339474
[TBL] [Abstract][Full Text] [Related]
12. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
[TBL] [Abstract][Full Text] [Related]
13. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.
Gutierrez JA; Mulder H; Jones WS; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Katona BG; Mahaffey KW; Norgren L; Hiatt WR; Patel MR
JAMA Netw Open; 2018 Nov; 1(7):e185239. PubMed ID: 30646395
[TBL] [Abstract][Full Text] [Related]
14. Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease.
Chen DC; Armstrong EJ; Singh GD; Amsterdam EA; Laird JR
Vasc Health Risk Manag; 2015; 11():185-92. PubMed ID: 25767395
[TBL] [Abstract][Full Text] [Related]
15. Statin Therapy Reduces Future Risk of Lower-Limb Amputation in Patients With Diabetes and Peripheral Artery Disease.
Hsu CY; Chen YT; Su YW; Chang CC; Huang PH; Lin SJ
J Clin Endocrinol Metab; 2017 Jul; 102(7):2373-2381. PubMed ID: 28398564
[TBL] [Abstract][Full Text] [Related]
16. Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
Bonaca MP; Nault P; Giugliano RP; Keech AC; Pineda AL; Kanevsky E; Kuder J; Murphy SA; Jukema JW; Lewis BS; Tokgozoglu L; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
Circulation; 2018 Jan; 137(4):338-350. PubMed ID: 29133605
[TBL] [Abstract][Full Text] [Related]
17. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
[TBL] [Abstract][Full Text] [Related]
18. Association between statin therapy and amputation-free survival in patients with critical limb ischemia in the CRITISCH registry.
Stavroulakis K; Borowski M; Torsello G; Bisdas T;
J Vasc Surg; 2017 Nov; 66(5):1534-1542. PubMed ID: 28807382
[TBL] [Abstract][Full Text] [Related]
19. Optimal medical management before lower extremity bypass for claudication in the veteran population.
Williams CR; Jellison A; Martin L; Zhang C; Presson AP; Kraiss LW; Brooke BS
J Vasc Surg; 2019 Feb; 69(2):545-554. PubMed ID: 30108008
[TBL] [Abstract][Full Text] [Related]
20. Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58.
Bonaca MP; Wiviott SD; Zelniker TA; Mosenzon O; Bhatt DL; Leiter LA; McGuire DK; Goodrich EL; De Mendonca Furtado RH; Wilding JPH; Cahn A; Gause-Nilsson IAM; Johanson P; Fredriksson M; Johansson PA; Langkilde AM; Raz I; Sabatine MS
Circulation; 2020 Aug; 142(8):734-747. PubMed ID: 32795086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
